CJC-1295 With DAC 5 mg

CJC-1295 with DAC 5 mg (10-Vial Bulk Pack)

Product Overview

CJC-1295 with DAC 5 mg is an advanced, high-purity synthetic analog of growth hormone-releasing hormone (GHRH) engineered for controlled in-vitro analysis, molecular research, and peptide-receptor affinity testing. By integrating a Drug Affinity Complex (DAC), this compound is structurally modified to covalently bind with endogenous albumin molecules. This bioconjugation significantly extends its half-life, providing researchers with a robust, long-acting tool to study sustained endocrine pathway stimulation at an increased 5 mg concentration.

The 10-Vial Bulk Advantage

Procuring this higher-concentration formulation in our 5 mg 10-Vial Multipack ensures absolute batch uniformity and data continuity over extended laboratory sequences. This bulk inventory tier minimizes variable testing parameters while providing a highly optimized procurement cost-per-mg baseline for active research facilities.

Key Research Focus Areas

• Extended Receptor Agonism: Specifically synthesized to evaluate long-term, uninterrupted activation profiles of growth hormone-releasing hormone receptors (GHRHR).

• Endocrine Axis Dynamics: Frequently utilized in molecular models to map continuous upstream signaling variations on downstream insulin-like growth factor 1 (IGF-1) matrices.

• Pharmacokinetic Testing: Ideal for research tracking cellular stability and peptide bioconjugation resistance in long-term plasma exposure studies.

Specifications & Storage

• Purity Matrix: Verified at 99% molecular purity via strict analytical validation and high-performance liquid chromatography.

• Format: Lyophilized, vacuum-sealed powder engineered to maximize compound stability and eliminate ambient environmental variables.

• Storage: Store at -20°C for long-term preservation, or keep refrigerated at 2°C to 8°C for active, immediate-use testing phases.

[ Secure Your 10-Vial CJC-1295 with DAC 5 mg Batch Today ]